(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Purity ≥98.0% (HPLC) Rivaroxaban Intermediate Factory

Short Description:

Chemical Name: (S)-(+)-Glycidyl Phthalimide

CAS: 161596-47-0

Appearance: White to Off-White Powder

Purity: ≥98.0% (HPLC)

Intermediate of Rivaroxaban (CAS: 366789-02-8) in the treatment of Venous Thromboembolism (VTE)

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply Rivaroxaban Related Intermediates:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-one CAS 438056-69-0
Rivaroxaban Intermediate CAS 446292-07-5
5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8

Chemical Properties:

Chemical Name	(S)-(+)-Glycidyl Phthalimide
Synonyms	(S)-Glycidyl Phthalimide; (S)-N-Glycidylphthalimide; Rivaroxaban Intermediate
CAS Number	161596-47-0
CAT Number	RF-PI128
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C11H9NO3
Molecular Weight	203.19
Melting Point	102℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White to Off-White Powder
Identification	HPLC
Loss on Drying	≤0.50%
Sulphate Ash	≤0.50%
Purity / Analysis Method	≥98.0% (HPLC)
Phthalimide	≤0.10%
Single Max Impurity	≤0.50%
Total Impurities	≤2.0%
Epichlorohydrin	≤0.10%
Glycidol	≤0.10%
Chiral Purity	R-isomer ≤2.0% (HPLC)
Test Standard	Enterprise Standard
Usage	Rivaroxaban (CAS: 366789-02-8) Intermediate

(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Synthesis Route

Package & Storage:

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-(+)-Glycidyl Phthalimide (CAS: 161596-47-0) with high quality. It is an intermediate typically in the synthesis of Rivaroxaban (CAS: 366789-02-8), in the treatment of Venous Thromboembolism (VTE).

Rivaroxaban (Xarelto; CAS: 366789-02-8) is an antithrombotic drug and was developed in a collaboration between the German Bayer Pharmaceuticals and American Johnson company. Rivaroxaban is indicated for the treatment of deep vein thrombosis and pulmonary embolism, and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults.